Anthony B. Evnin, Director at INFINITY PHARMACEUTICALS, INC. (INFI), sold 22,480 shares at $25.28 ($565K) on 2012-11-27, disclosed to the SEC on 2012-11-29.
Open-market sale of $565k INFI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.28 | 17,648 | $446K | 78.9% |
| 2 | $24.62 | 4,832 | $119K | 21.1% |
| Total | $25.14 avg | 22,480 | $565K | 100% |
| Filing → |
| CNST | BUY | 2019-10-04 | $48.0M | — | Filing → |
| AVEO | BUY | 2018-11-26 | $223 | — | Filing → |
| AVEO | SELL | 2018-11-16 | $4.3M | — | Filing → |